Homoharringtonine Sodium Chloride Injection
Indication
It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute myeloid leukemia. It also has certain effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia, and polycythemia vera.
Packaging Specification
100ml: Homoharringtonine 2mg and sodium chloride 0.9g
Manufacturer
Gansu Fuzheng Pharmeceutical SCI & Tech Co., Ltd.
-
Founded in:
2002-09-19 -
Address:
Cankou Industrial Development Zone, Anding District, Dingxi City, Gansu Province -
Tax NO.:
91620000739649852R -
Registered Funds:
144.78 million yuan -
Email: